The clinical spectrum of anti-CASPR2 autoimmunity is broad, including limbic encephalitis, peripheral nerve hyperexcitability (neuromyotonia), cerebellar ataxia, and prominent autonomic dysfunction and insomnia (which may manifest as Morvan syndrome) (6, 7). Here, CNTNAP2 is linked to Morvan syndrome.